Federal contract award
W81K0225FA133
EQUIPMENT LEASE CONTRACT FOR TWO MULTIPLEX MOLECULAR ANALYZER SYSTEMS AND THE SUPPLY OF TESTING PANEL REAGENTS MADIGAN ARMY MEDICAL CENTER (MAMC) DEPARTMENT OF PATHOLOGY
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | DEFENSE HEALTH AGENCY HCD WEST |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets |
| Parent award / vehicle | W81K0225DA010 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $968.3K |
| Current contract value | $968.3K |
| Potential contract value / ceiling | $968.3K |
| Start date | Oct 1, 2025 |
| Current end date | Sep 30, 2026 |
| Potential end date | Sep 30, 2026 |
| Latest award activity | Apr 2, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Apr 2, 2026 | P00003 | $0 | EQUIPMENT LEASE CONTRACT FOR TWO MULTIPLEX MOLECULAR ANALYZER SYSTEMS AND THE SUPPLY OF TESTING PANEL REAGENTS MADIGAN ARMY MEDICAL CENTER (MAMC) DEPARTMENT OF PATHOLOGY |
| Mar 24, 2026 | P00002 | $0 | EQUIPMENT LEASE CONTRACT FOR TWO MULTIPLEX MOLECULAR ANALYZER SYSTEMS AND THE SUPPLY OF TESTING PANEL REAGENTS MADIGAN ARMY MEDICAL CENTER (MAMC) DEPARTMENT OF PATHOLOGY |
| Jan 27, 2026 | P00001 | $968.3K | EQUIPMENT LEASE CONTRACT FOR TWO MULTIPLEX MOLECULAR ANALYZER SYSTEMS AND THE SUPPLY OF TESTING PANEL REAGENTS MADIGAN ARMY MEDICAL CENTER (MAMC) DEPARTMENT OF PATHOLOGY |
| Sep 11, 2025 | 0 | $0 | EQUIPMENT LEASE CONTRACT FOR TWO MULTIPLEX MOLECULAR ANALYZER SYSTEMS AND THE SUPPLY OF TESTING PANEL REAGENTS MADIGAN ARMY MEDICAL CENTER (MAMC) DEPARTMENT OF PATHOLOGY |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.